Living with Gout? Join a No-Cost Gout Research Study
Now Enrolling Ages 18-75 for a Gout Research Study
See If You Qualify
- No cost to check eligibility
- No obligation to participate
- A coordinator confirms eligibility by phone
- You can withdraw at any time
This pre-screening does not guarantee enrollment.
Overview
We are currently enrolling participants for a clinical trial exploring an investigational treatment for gout. Researchers are studying a potential new, non-opioid treatment for people with gout, and your participation is critical to helping discover new ways to potentially manage this condition.
Ready to make a difference?
Take our quick prescreener now and see if you qualify for our research study on gout.
About the Study
Gout flares are not only painful but also can be very frustrating. A lot of people who suffer from gout still struggle with symptoms even when on medication such as allopurinol. This program is evaluating the effectiveness of the study drug, dotinurad, compared to other gout medicine in lowering serum uric acid (the waste product that builds up in the blood, leading to gout symptoms).
Patients Diagnosed with Gout
Patients Diagnosed with Tophaceous Gout
Benefits
Compensation
Reimbursement for reasonable study-related expenses (travel and meals)
Study-Related Care
Monitoring by the study team throughout the study
Medication
Participants will receive: ο· The study drug, dotinurad, or other study-supplied gout medicine ο· Medication to prevent gout flares
Who Can Join
18-75 years old
Diagnosed with gout for at least 1 year
Had at least 2 flares in the past 12 months
Currently taking allopurinol (β₯300 mg/day or β₯200 mg/day with kidney issues) up to 600 mg/day for at least 3 months prior to screening
BMI is between 18.5 to 45
*Other conditions may apply
What to Expect
* Eligible participants may receive compensation for completing all required study-related activities.
Participating Locations
Know Someone Who Might Qualify?
Share this study with a friend or family member who may benefit.